Physician profile
Behdad Javdan
NPI 1104276765
$5,551.13
in general payments reported to CMS, 2019-2025
13 companies · $301 in 2025
The $301 reported for 2025 was more than what 75% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,961 · 2020: $1,310 · 2021: $61.69 · 2022: $423 · 2023: $318 · 2024: $176 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610 · Gift: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.17 |
| Gift | $185.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,216.16 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $1,100.71 | 2019 | |
| Biohorizons Implant Systems INC. | $380.59 | 2019-2025 | Biohorizons, Biohorizons Dental Prosthetics |
| Ultradent Products INC | $279.00 | 2022 | |
| Purelife, LLC | $185.00 | 2025 | |
| Dentsply Sirona INC | $124.21 | 2019-2024 | Ossix Plus |
| Geistlich Pharma, North America, INC. | $78.13 | 2021-2025 | Biomaterials |
| Salvin Dental Specialties, INC. | $56.15 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $54.95 | 2019-2023 | Arestin |
| Nobel Biocare USA | $29.65 | 2022 | |
| Ace Surgical Supply Co., INC. | $18.57 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $14.14 | 2023 | |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $13.87 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Behdad Javdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.